Sunshine Biopharma Inc (SBFM)

[Glopez]

It can fairly be described as a surprise split because the company released a prospectus alleging that everything, including the R/S ratio, was subject to change. The company further conditioned the split on NASDAQ approval. Furthermore, Rosen pumped the stock on news of a “roadshow”; and typically, the final prospectus and r/s ratio are released after the roadshow.

Clearly, the roadshow is expected to be a DUD.

But SBFM clearly had no intention of changing the ratio downwards, so they should not have lied and alleged that the information in the prospectus was subject to change. Clearly, SBFM intended to do the R/S at 200 to 1 and that was not really something that was expected to change.

I mean, I can go on…

This company is trash, accept it.